Diseases of the genitourinary system. Excessive, frequent and irregular menstruation
Conditions
Interventions
Intervention 1: Intervention:30paitents misoprostol one tablet(200 micro gr)was inserted in the vagina 4 hours before surjery for one time. Intervention 2: Control :In 30paisents one placebo ta
Treatment - Other
Placebo
Intervention:30paitents misoprostol one tablet(200 micro gr)was inserted in the vagina 4 hours before surjery for one time.
Control :In 30paisents one placebo tablet was inserted in vagina 4hours befor surjery for one time.
Sponsors
vice- chancellor for research , Qazvin univercity of medical sciences and health services
Eligibility
Sex/Gender
Female
Age
27 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria :patints with abnormal uterine bleeding who are candidate for dilation and curretage exclusion criteria :systemic diseases ; cervical and vaginal infections; history of allergy to prostaglandins ; sever anemia or coagulopathy; anticoagulant therapy; history of cervical surgery;pregnancy; lactation; menopause; suspicious endocervical or exocervical erosions;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dilation of cervix as much as hegar dilator numbr five. Timepoint: four hour after using drug. Method of measurement: passage of hegar dilator numbr five. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in operation time. Timepoint: During operation. Method of measurement: Measurement with chronometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Khadijeh Elmizadeh
Qazvin , university of medical sciences and health services
Outcome results
None listed